JAZZ

Jazz Pharmaceuticals plc

Pharmaceuticals · Pharmaceuticals

$247.26 sample

-2.21 (-0.89%) 1D

Market cap

$1.52T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-09

Alerts

8

Price$247.26 +4.95% 3M daily closessample

264.94235.59

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: General Counsel
Sep 23INSInsider buy: Director
Sep 15INSInsider buy: Chief Financial Officer
Sep 09SEC8-K filed: material event
Sep 03INSInsider buy: General Counsel
Aug 28INSInsider sell: EVP, Operations
Aug 25SECForm 144 filed
Aug 18INSInsider sell: Chief Financial Officer

Sign up to see the real JAZZ record →

Company facts

SEC EDGAR registration

Name: Jazz Pharmaceuticals plc
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -52sample, -100 to +100
Reporting currency: USD

Who is positioning in JAZZ

sample

Insiders: 28 insider transactions over 90 days, net selling, $237.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 10 funds hold $19.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$101.5B +22.0% y/y

Q4 2024Q3 2026

Inventory$61.1B +13.6% y/y

Q4 2024Q3 2026

Accounts receivable$42.3B +12.0% y/y

Q4 2024Q3 2026

Total debt$112.7B +6.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.01T +1.6% 3M
Sample peer B: $658.9B +3.7% 3M
Sample peer C: $996.5B +0.8% 3M
Sample peer D: $484.7B +9.9% 3M
Sample peer E: $1.34T -3.7% 3M